Logo image of NHTC

NATURAL HEALTH TRENDS CORP (NHTC) Stock Fundamental Analysis

NASDAQ:NHTC - Nasdaq - US63888P4063 - Common Stock - Currency: USD

4.22  -0.05 (-1.17%)

Fundamental Rating

3

Overall NHTC gets a fundamental rating of 3 out of 10. We evaluated NHTC against 35 industry peers in the Personal Care Products industry. NHTC has a great financial health rating, but its profitability evaluates not so good. NHTC has a expensive valuation and it also scores bad on growth. Finally NHTC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year NHTC was profitable.
In the past year NHTC has reported a negative cash flow from operations.
In the past 5 years NHTC has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: NHTC reported negative operating cash flow in multiple years.
NHTC Yearly Net Income VS EBIT VS OCF VS FCFNHTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

The Return On Assets of NHTC (0.77%) is comparable to the rest of the industry.
NHTC has a Return On Equity of 1.21%. This is comparable to the rest of the industry: NHTC outperforms 60.00% of its industry peers.
Industry RankSector Rank
ROA 0.77%
ROE 1.21%
ROIC N/A
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
NHTC Yearly ROA, ROE, ROICNHTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

NHTC has a Profit Margin (0.83%) which is in line with its industry peers.
NHTC's Profit Margin has declined in the last couple of years.
NHTC has a Gross Margin of 73.97%. This is amongst the best in the industry. NHTC outperforms 85.71% of its industry peers.
In the last couple of years the Gross Margin of NHTC has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 0.83%
GM 73.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
NHTC Yearly Profit, Operating, Gross MarginsNHTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NHTC has about the same amount of shares outstanding.
NHTC has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NHTC Yearly Shares OutstandingNHTC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NHTC Yearly Total Debt VS Total AssetsNHTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.37 indicates that NHTC is not a great score, but indicates only limited risk for bankruptcy at the moment.
NHTC has a Altman-Z score of 2.37. This is comparable to the rest of the industry: NHTC outperforms 42.86% of its industry peers.
NHTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.37
ROIC/WACCN/A
WACC8.98%
NHTC Yearly LT Debt VS Equity VS FCFNHTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

NHTC has a Current Ratio of 2.73. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
NHTC has a Current ratio of 2.73. This is in the better half of the industry: NHTC outperforms 68.57% of its industry peers.
NHTC has a Quick Ratio of 2.55. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NHTC (2.55) is better than 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.55
NHTC Yearly Current Assets VS Current LiabilitesNHTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for NHTC have decreased strongly by -66.67% in the last year.
NHTC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.90% yearly.
NHTC shows a decrease in Revenue. In the last year, the revenue decreased by -2.08%.
NHTC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.15% yearly.
EPS 1Y (TTM)-66.67%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-2.08%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-6.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHTC Yearly Revenue VS EstimatesNHTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
NHTC Yearly EPS VS EstimatesNHTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 0.01 0.02 0.03 0.04 0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 140.67, which means the current valuation is very expensive for NHTC.
Compared to the rest of the industry, the Price/Earnings ratio of NHTC indicates a slightly more expensive valuation: NHTC is more expensive than 60.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.85, NHTC is valued quite expensively.
Industry RankSector Rank
PE 140.67
Fwd PE N/A
NHTC Price Earnings VS Forward Price EarningsNHTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NHTC Per share dataNHTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 18.35%, NHTC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.56, NHTC pays a better dividend. On top of this NHTC pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, NHTC pays a better dividend.
Industry RankSector Rank
Dividend Yield 18.35%

5.2 History

The dividend of NHTC has a limited annual growth rate of 4.44%.
NHTC has paid a dividend for at least 10 years, which is a reliable track record.
NHTC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years10
NHTC Yearly Dividends per shareNHTC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

2647.41% of the earnings are spent on dividend by NHTC. This is not a sustainable payout ratio.
DP2647.41%
EPS Next 2YN/A
EPS Next 3YN/A
NHTC Yearly Income VS Free CF VS DividendNHTC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
NHTC Dividend Payout.NHTC Dividend Payout, showing the Payout Ratio.NHTC Dividend Payout.PayoutRetained Earnings

More info and screens

NATURAL HEALTH TRENDS CORP

NASDAQ:NHTC (8/19/2025, 4:12:48 PM)

4.22

-0.05 (-1.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-28 2025-10-28
Inst Owners9.72%
Inst Owner Change67.27%
Ins Owners15.6%
Ins Owner Change0%
Market Cap48.57M
Analysts0
Price TargetN/A
Short Float %0.31%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield 18.35%
Yearly Dividend0.8
Dividend Growth(5Y)4.44%
DP2647.41%
Div Incr Years0
Div Non Decr Years10
Ex-Date08-12 2025-08-12 (0.2)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 140.67
Fwd PE N/A
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)0.03
EY0.71%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS3.66
BVpS2.51
TBVpS2.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.83%
GM 73.97%
FCFM N/A
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.84%
Cap/Sales 0.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.55
Altman-Z 2.37
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)47.19%
Cap/Depr(5y)53.89%
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.08%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-6.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.25%
OCF growth 3YN/A
OCF growth 5YN/A